Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Cole

Showing results (151-160 of 210) with videos related to

Pageof 21
Sort By:
The Journal of Biological Chemistry|January 27, 1995
A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilageD Chan, W G Cole, C W Chow, et al.
Journal of Medical Genetics|February 1, 1992
The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagenW G Cole, E Patterson, J Bonadio, et al.
The Journal of Bone and Joint Surgery. British Volume|November 1, 1990
Development of the hip in multiple epiphyseal dysplasia. Natural history and susceptibility to premature osteoarthritisN J Treble, F O Jensen, A Bankier, et al.
The Journal of Biological Chemistry|August 25, 1988
Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNAJ F Bateman, S R Lamande, H H Dahl, et al.
The Journal of Biological Chemistry|May 25, 1987
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagenJ F Bateman, D Chan, I D Walker, et al.
The Journal of Biological Chemistry|April 25, 1986
Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VIIW G Cole, D Chan, G W Chambers, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic ricketsO Mäkitie, A Doria, S W Kooh, et al.
The Biochemical Journal|July 1, 1989
Changes in collagen stability and folding in lethal perinatal osteogenesis imperfecta. The effect of alpha 1 (I)-chain glycine-to-arginine substitutionsA T Baker, J A Ramshaw, D Chan, et al.
Journal of Medical Genetics|November 1, 1996
Disrupted growth plates and progressive deformities in osteogenesis imperfecta as a result of the substitution of glycine 585 by valine in the alpha 2 (I) chain of type I collagenW G Cole, D Chan, C W Chow, et al.
Journal of Pediatric Orthopedics|September 1, 1988
Outpatient treatment of upper extremity injuries in childhood using intravenous regional anaesthesiaB W Olney, P C Lugg, P L Turner, et al.
Pageof 21

Showing results (151-160 of 210) with videos related to

Sort By:
Pageof 21
The Journal of Biological Chemistry|January 27, 1995
A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilageD Chan, W G Cole, C W Chow, et al.
Journal of Medical Genetics|February 1, 1992
The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagenW G Cole, E Patterson, J Bonadio, et al.
The Journal of Bone and Joint Surgery. British Volume|November 1, 1990
Development of the hip in multiple epiphyseal dysplasia. Natural history and susceptibility to premature osteoarthritisN J Treble, F O Jensen, A Bankier, et al.
The Journal of Biological Chemistry|August 25, 1988
Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNAJ F Bateman, S R Lamande, H H Dahl, et al.
The Journal of Biological Chemistry|May 25, 1987
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagenJ F Bateman, D Chan, I D Walker, et al.
The Journal of Biological Chemistry|April 25, 1986
Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VIIW G Cole, D Chan, G W Chambers, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic ricketsO Mäkitie, A Doria, S W Kooh, et al.
The Biochemical Journal|July 1, 1989
Changes in collagen stability and folding in lethal perinatal osteogenesis imperfecta. The effect of alpha 1 (I)-chain glycine-to-arginine substitutionsA T Baker, J A Ramshaw, D Chan, et al.
Journal of Medical Genetics|November 1, 1996
Disrupted growth plates and progressive deformities in osteogenesis imperfecta as a result of the substitution of glycine 585 by valine in the alpha 2 (I) chain of type I collagenW G Cole, D Chan, C W Chow, et al.
Journal of Pediatric Orthopedics|September 1, 1988
Outpatient treatment of upper extremity injuries in childhood using intravenous regional anaesthesiaB W Olney, P C Lugg, P L Turner, et al.
Pageof 21